Quantcast

Latest Pulmonology Stories

2014-05-19 08:27:35

MOUNTAIN VIEW, Calif., May 19, 2014 /PRNewswire/ -- A revolutionary new treatment for severe emphysema, which could potentially help millions of patients suffering from a debilitating disease, has been featured recently on national media channels across the US. Leading pulmonologists and premier medical centers have been reaching out to media outlets to share their enthusiasm about RePneu endobronchial coil therapy - a new treatment for emphysema patients. The stories have...

2014-05-18 16:20:52

-- Two Phase 3 trials met primary endpoint of reduction in annual rate of lung function decline RIDGEFIELD, Conn., May 18, 2014 /PRNewswire/ -- Boehringer Ingelheim announced the results of its two pivotal Phase 3 INPULSIS(TM) trials (INPULSIS(TM)-1 and -2; NCT01335464 and NCT01335477), which were published online today in the New England Journal of Medicine (NEJM). The INPULSIS(TM) trials evaluated the efficacy and safety of nintedanib, an investigational therapy being studied in people with...

2014-05-16 08:24:21

Now includes information about InterMune's Expanded Access Program CHICAGO, May 16, 2014 /PRNewswire/ -- The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone. "The Pulmonary Fibrosis Foundation (PFF) is committed to serve as an impartial resource for the PF community,"...

2014-05-15 23:06:12

Local Stem Cell Clinic Celebrates Anniversary with Hundreds of Patients Treated Tampa, Florida (PRWEB) May 15, 2014 On Tuesday, May 20, Lung Institute is celebrating the first anniversary of its Tampa location. As a leader in regenerative medicine, Lung Institute has provided over 250 treatments to lung disease patients who previously had no hope for better breathing and regaining quality of life. Lung Institute treats lung diseases including pulmonary fibrosis and chronic obstructive...

2014-05-15 04:22:31

OXFORD, England, May 15, 2014 /PRNewswire/ -- First full presentation of data from randomised clinical study of glycopyrronium bromide made using Prosonix' novel particle-engineering technology Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it will present results from its Phase 2 clinical study with PSX1002 in patients with moderate to severe chronic obstructive...

2014-05-13 23:04:08

ReportsnReports.com adds “Pulmonary Drug Delivery Market & Clinical Pipeline Insight” report to its research database. Dallas, Texas (PRWEB) May 13, 2014 The demand for new and innovative drug delivery systems has been on a rising trend with the pharmaceutical companies concentrating on developing innovative methods in this area. It is the result of these continued efforts, which have led to the ever rising popularity of pulmonary drug delivery methods across the globe. The...

2014-05-09 13:07:48

University of Illinois By simply carrying around their cellphones, patients who suffer from chronic disease could soon have an accurate health monitor that warns their doctors when their symptoms worsen. GaitTrack, an app developed by researchers at the University of Illinois at Urbana-Champaign and the U. of I. at Chicago, turns a smartphone into a sophisticated medical device. Unlike other apps that merely count steps, GaitTrack uses eight motion parameters to perform a detailed...

2014-05-08 08:33:40

Fully Rotatable and Ultra-Slim Bronchoscopes Designed to Extend Reach Within Tracheobronchial Tree CENTER VALLEY, Pa., May 8, 2014 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative diagnostic and therapeutic solutions in Medical and Surgical procedures, among other core businesses, announced today the commercial availability of its 510(k) cleared, next-generation BF-P190 and BF-XP190 bronchoscopes for peripheral and small anatomy bronchoscopy....

2014-05-08 08:33:14

IRVING, Texas, May 8, 2014 /PRNewswire-USNewswire/ -- Glyceryl guaiacolate ether (GGE) is unlikely to make it easier to cough up phlegm when delivered in the recommended dose. GGE is approved by the FDA as an over-the-counter expectorant and is the active ingredient in Mucinex extended-release and many other cold remedies on the market. The study was published in the May 2014 issue of RESPIRATORY CARE, a journal of the American Association for Respiratory Care. A total of 295 subjects...

2014-05-06 08:34:36

Pledge to Raise Funding to Send Deserving Children with Asthma to Summer Camps Across the U.S. VIENNA, Va., May 6, 2014 /PRNewswire/ -- Know Your Count - a national campaign aimed at raising awareness of the seriousness of asthma and educating patients and caregivers about the importance of keeping track of the remaining doses in their rescue inhalers - announced today the launch of a new online pledge for asthma awareness. Nearly seven million children in the United States are...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related